Skip to main content

DCVC — Portfolio, Page 5

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

285
Companies
$5.9B
Total invested
$32.0M
Avg. check
61
Industries
Biotechnology 8Software 5Health Care 5Information Technology 5Life Science 4Medical 4+55 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 97120 of 285
Horizon Quantum
March 2023

Horizon Quantum Computing builds software development tools to code, compile and deploy quantum applications from classical code.

Computer · Singapore$18.1M Series A
Shennon Biotechnologies
March 2023

ShennonBio analyzes and manipulates a massive number of cells on the single cell level to develop better treatments for human diseases.

Biotechnology · San Francisco$13.0M Seed
evonetix
February 2023

Evonetix is a provider of a desktop platform designed to synthesize DNA at unprecedented accuracy and scale.

Biopharma · Little Chesterford$24.1M Series B
Recycleye
February 2023

Recycleye is a developer of digital tools designed to detect and provide analytics on waste management.

Analytics · London$17.0M Series A
Entocycle
January 2023

Entocycle develops the technology to enable efficient and scalable insect farming.

Agriculture · London$5.0M Series A
Orca Bio
January 2026

Orca Bio is a clinical-stage cell therapy company dedicated to delivering curative medicine to patients.

Health Care · Menlo Park$250.0M Series F
Medical Informatics
January 2025

Medical Informatics offers solutions that give care teams access to the data they need to take action for alarm management and safety.

Health Care · Houston$5.0M Debt Financing
Enlitic
December 2025

Enlitic builds AI deep learning products to streamline radiologists' workflows and improve healthcare diagnosis.

Analytics · Fort Collins$7.1M Post-IPO Debt
Superfluid Dx
December 2023

Superfluid Dx is a biotechnology company developing novel blood-based early detection.

Biotechnology · San DiegoSeries A
CodeSee
January 2022

CodeSee is a developer of cloud-based data visualization software to help users master the understanding of code.

Developer Tools · San Francisco$7.0M Seed
CH4 Global
January 2025

CH4 Global mission is to use sustainable aquaculture to impact climate change at scale.

Agriculture · HendersonCorporate Round
Umoja Biopharma
January 2025

Umoja Biopharma is a biopharmaceutical company developing next-generation immunotherapies intended to combat cancer.

Biopharma · Seattle$100.0M Series C
Zoom
November 2021

Zoom is a software company that offers a communications platform that connects people through video, voice, chat, and content sharing.

Artificial Intelligence (AI) · San Jose$130.0M Post-IPO Equity
Proxima
January 2026

Proxima Bio develops programmable medicines that modulate protein interactions to address disease processes.

Alternative Medicine · New York$91.5M Seed
Curative
November 2025

Curative provides employer-based health insurance plans and healthcare services.

Employee Benefits · Austin$150.0M Series B
The San Francisco Compute Company
November 2025

The San Francisco Compute Company manufactures supercomputers.

Information Technology · San Francisco$40.0M Series A
Nium
January 2025

Nium develops patent pending nanotechnology that produces greener ammonia.

Chemical Engineering · HarwellNon-equity Assistance
Aura Frames
November 2022

Aura Frames offers a smart picture frame designed to fill homes with beautiful photos of family and friends.

Consumer Electronics · New York$26.0M Series B
Gradle Inc.
November 2021

Gradle provides the most popular open source build tool for the Java ecosystem and the Develocity commercial build analytics solution

Analytics · San Francisco$27.0M Series C
Kettle
November 2021

Kettle is an insurtech company that develops a machine-learning powered reinsurer balancing risk.

Financial Services · Hamilton$25.0M Series A
Amogy
November 2025

Amogy offers carbon-free energy solutions using ammonia cracking technology.

Clean Energy · Brooklyn$15.0M Venture - Series Unknown
ElectronX
November 2025

ElectronX is an energy exchange focusing on managing short-term price volatility in the electricity market.

Energy · Chicago$30.0M Series A
Nyriad
November 2021

Nyriad is developing the industry's first storage solutions based on a new architecture that redefines how data is stored.

Computer · Austin$28.0M Series C
Smartex.ai
November 2024

Smartex.ai is an AI and computer vision company that uses automated inspection to detect textile defects.

Artificial Intelligence (AI) · PortoNon-equity Assistance

Where DCVC invests

Biotechnology8
Software5
Health Care5
Information Technology5
Life Science4
Medical4

About DCVC's portfolio

How many companies has DCVC invested in?

DCVC has invested in 285 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does DCVC invest in?

DCVC's top investment sectors include Biotechnology, Software, Health Care, Information Technology, Life Science. The firm invests across 61 different industry categories.

What is DCVC's largest investment?

Among tracked funding rounds, Orca Bio received $250.0M in a Series F round. DCVC's total known invested capital is $5.9B.

What is the average investment size for DCVC?

DCVC's average investment size is $32.0M across its portfolio of 285 companies.

What are DCVC's most recent investments?

Recent DCVC portfolio additions include Horizon Quantum, Shennon Biotechnologies, evonetix, Recycleye, Entocycle. These companies were founded in 2020 or later.

Reach the founders behind these 285 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →